Cabaletta Bio (CABA) Cash & Current Investments (2018 - 2025)

Cabaletta Bio's Cash & Current Investments history runs 8 years deep, the most recent figure standing at $133.6 million for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 18.52% year-over-year to $133.6 million; the TTM figure through Dec 2025 stood at $133.6 million (down 18.52% YoY), while the FY2025 annual figure was $133.6 million, down 18.52% from the prior year.
• Cash & Current Investments was $133.6 million for Q4 2025 at Cabaletta Bio, down from $159.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $272.4 million in Q1 2024 to a low of $93.8 million in Q1 2023.
• Historically, Cash & Current Investments has averaged $161.5 million across 5 years, with a median of $152.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 190.26% in 2024, then tumbled 51.6% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $122.2 million in 2021, then decreased by 12.83% to $106.5 million in 2022, then jumped by 126.42% to $241.2 million in 2023, then tumbled by 32.04% to $164.0 million in 2024, then fell by 18.52% to $133.6 million in 2025.
• The last three Cash & Current Investments figures came in at $133.6 million (Q4 2025), $159.9 million (Q3 2025), and $194.7 million (Q2 2025), per Business Quant data.